MBL Wealth’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-779
Closed -$230K 391
2026
Q1
$230K Sell
779
-223
-22% -$66.2K 0.02% 300
2025
Q4
$274K Buy
1,002
+24
+2% +$6.52K 0.02% 247
2025
Q3
$264K Sell
978
-33
-3% -$8.98K 0.02% 219
2025
Q2
$279K Sell
1,011
-57
-5% -$15.5K 0.03% 199
2025
Q1
$283K Sell
1,068
-245
-19% -$60.4K 0.03% 182
2024
Q4
$305K Buy
1,313
+309
+31% +$71.1K 0.03% 173
2024
Q3
$222K Buy
+1,004
New +$208K 0.02% 192
2024
Q2
Sell
-1,300
Closed -$280K 211
2024
Q1
$280K Sell
1,300
-38
-3% -$7.98K 0.03% 159
2023
Q4
$282K Buy
+1,338
New +$285K 0.04% 143

Other funds holding CME

MBL Wealth's CME Position: Q2 2026 in Review

MBL Wealth sold out of CME Group (CME) in Q2 2026, closing a stake of 779 shares — an estimated $230K sold.

MBL Wealth first reported a position in CME in Q4 2023 and held it in 9 quarters. The position peaked at $305K in Q4 2024. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • MBL Wealth reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • MBL Wealth sold 779 CME Group shares in Q2 2026, an estimated $230K.
  • MBL Wealth first reported a position in CME Group in Q4 2023 and held it in 9 quarters.
  • MBL Wealth's CME Group position peaked at $305K in Q4 2024.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.